Induction of chronic autoimmune arthritis in DBA/1 mice by oral administration of type II collagen and Escherichia coli lipopolysaccharide

British Journal of Rheumatology

Volumn 35, Issue 9, 1996, Pages 828-838

  Terato, K ^a   Ye, X J ^b   Miyahara, H ^c   Cremer, M A ^b   Griffiths, M M ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Autoantibody; Collagen induced arthritis; Lipopolysaccharide; Mice; Mucosal permeability; NSAID; Oral immunization; Ovoinhibitor; Rheumatoid arthritis; Type II collagen

Indexed keywords

ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; COLLAGEN TYPE 2; PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTHRITIS; ARTICLE; AUTOIMMUNITY; BONE DESTRUCTION; CHICKEN; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI; ETIOLOGY; GASTROINTESTINAL ABSORPTION; INGESTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ANIMALS; ARTHRITIS; AUTOIMMUNE DISEASES; CHRONIC DISEASE; COLLAGEN; CROSS REACTIONS; ESCHERICHIA COLI; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED DBA;

EID: 0029823508     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Gregersen P, Silver J, Winchester R. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
2. Wordsworth B, Lanchbury J, Sakkas L, Welsh K, Panayi G, Bell J. HLA-DR4 subtype frequency in rheumatoid arthritis indicates that DRB1 is the major susceptibility locus with the human leukocyte antigen class II region. Proc Natl Acad Sci USA 1989;86:10049-53.
3. Stastny P, Ball E, Kahn M, Olsen N, Pincus T, Gao X. HLA-DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol 1988;27:132-8.
4. Roudier J, Rhodes G, Petersen J. A hypothesis: The Epstein-Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis. Scand J Immunol 1988;27:367-71.
5. Kaufmann S. Heatshock proteins: a link between rheumatoid arthritis and infection. Curr Opin Rheumatol 1990;2:430-5.
6. Perez-Maceda B, Lopez-Bote JP, Langa C, Bernabeu C. Antibodies to dietary antigens in rheumatoid arthritis - possible molecular mimicry mechanism. Clin Chim Acta 1991;203:153-65.
7. Terato K, Shimozuru Y, Katayama K et al. Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum 1990;33:1493-500.
8. Drake C, Kotzin B. Superantigens: Biology, immunology, and potential role in disease. J Clin Immunol 1992;12:149-62.
9. Paliard X, West SG, Lafferty JA et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991;253:325-9.
10. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146:857-68.
11. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunization against heterologous type II collagen includes arthritis in mice. Nature 1980;283:666-8.
12. Cathcart ES, Hayes KC, Gonnerman WA, Lazzari AA, Franzblau C. Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen. Lab Invest 1986;54:26-31.
13. Terato K, Arai H, Shimozuru Y et al. Sex-linked differences in susceptibility of cynomolgus monkeys to type II collagen-induced arthritis. Arthritis Rheum 1989;32:748-58.
14. Jasin HE. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1985;28:241-8.
15. Watson WC, Tooms RE, Carnesale PG, Dutkowsky JP. A case of germinal center formation by CD45RO T and CD20B lymphocytes in rheumatoid arthritic subchondral bone: Proposal for a two-compartment model of immune-mediated disease with implications for immuno-therapeutic strategies. Clin Immunol Immunopathol 1994;73:27-37.
16. Wooley PH, Luthra HS, Singh S, Huse A, Stuart JM, David CS. Passive transfer of arthritis in mice by human anti-type II collagen antibody. Mayo Clin Proc 1984;59:737-43.
17. Kuniaki Terato, DeArmey DA, Ye XJ, Cremer MA, Griffiths MM. The mechanism of autoantibody formation to cartilage in rheumatoid arthritis: Possible cross-reaction of antibodies to dietary collagens with autologous type II collagen. Clin Immunol Immunopathol 1996;79:142-54.
18. Terato K, Harper DS, Griffiths MM et al. Collagen-induced arthritis in mice: Synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity 1995;22:137-47.
19. O'Mahony S, Ferguson A. Small intestinal mucosal protection mechanisms and their importance in rheumatology. Ann Rheum Dis 1991;50:331-6.
20. Miller E. Isolation and characterization of a collagen from chick cartilage containing three identical α-chains. Biochemistry 1971;10:1652-9.
21. Terato K, Hashida R, Miyamoto K et al. Histological, immunological and biochemical studies on type II collagen-induced arthritis in rats. Biomed Res 1982;3:495-505.
22. Miller EJ. Isolation and characterization of the cyanogen bromide peptides from the α1(II) chain of chick cartilage collagen. Biochemistry 1971;10:3030-5.
23. Terato K, Hasty KA, Cremer MA, Stuart JM, Townes AS, Kang AH. Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J. Exp Med 1985;162:637-46.
24. Terato K, Hasty KA, Reife R, Cremer MA, Stuart JM, Kang AH. Induction of arthritis with monoclonal antibodies to collagen. J Immunol 1992;148:2103-8.
25. Fujii K, Tsuji M, Murota K, Terato K, Shimozuru Y, Nagai Y. An improved enzyme-linked immunosorbent assay of anti-collagen antibodies in human serum. J Immunol Methods 1989;124:63-70.
26. Terato K, Cremer MA, Hasty KA, Kang AH, Hasty DL, Townes AS. Physicochemical and immunological studies of the renatured α1(II) chains and isolated cyanogen bromide peptides of type II collagen. Collagen Rel Res 1985;5:469.
27. Glauser MP, Zanetti G, Baumgartner J-D, Xohen L. Septic shock: pathogenesis. Lancet 1991;338:732-6.
28. Myers LK, Terato K, Seyer JM, Stuart JM, Kang AH. Characterization of a tolerogenic T cell epitope of type II collagen and its relevance to collagen-induced arthritis. J Immunol 1992;149:1439-43.
29. Swann DA, Constable IJ, Harper E. Vitreous structure. 3. Composition of bovine vitreous collagen. Invest Ophthalmol 1972;11:735-8.
30. Wooley PH, Luthra HS, Griffiths MM, Stuart JM, Huse A, David CS. Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol 1985;135:2443-51.
31. Griffiths MM, Cremer MM, Harper DS, MaCall S, Cannon GW. Immunogenetics of collagen-induced arthritis in rats. Both MHC and non-MHC gene products determine the epitope-specificity of immune response to bovine and chick type II collagens. J Immunol 1992;149:309-16.
32. Nabozny GH, Baisch JM, Cheng S et al. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med 1996;183:27-37.
33. Griffiths MM, Sawitzke AD, Harper DS et al. Exacerbation of collagen-induced arthritis in rats by rat cytomegalovirus is antigen-specific. Autoimmunity 1994;18:177-87.
34. Husby S, Jensenius JC, Svehag S-E. Passage of undigested dietary antigen into the blood of healthy adults. Quantification, estimation of the size distribution, and relation of uptake to levels of specific antibodies. Scand J Immunol 1985;22:83-92.
35. Walker WA, Isselbacher KJ, Bloch KJ. Intestinal uptake of macromolecules: Effect of oral immunization. Science 1972;177:608-10.
36. Czerkinsky C, Prince S, Michalrk S et al. IgA antibody-producing cells in peripheral blood after antigen ingestion: Evidence for a common mucosal immune system in humans. Proc Natl Acad Sci USA 1987;85:2449-53.
37. Delacroix DL, Hodgson A, Dive C, Vaerman JP. Selective transport of polymeric immunoglobulin A in bile: Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest 1982;70:230-41.
38. Xu-Amano J, Aicher WK, Taguchi T, Kiyono H, McGhee J. Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Int Immunol 1992;4:433-45.
39. Brandtzaeg P, Barklien K, Bjenke K, Rognum TO. Nature and properties of the human gastrointestinal immune system. Boca Raton, FL: CRC Press Inc., 1987.
40. Kent TH. Staphylococcal enterotoxin gastroenteritis in rhesus monkeys. Am J Pathol 1966;48:387-407.
41. Beery JT, Taylor SL, Schlunz LR, Freed RC, Merlin S. Effects of staphylococcal enterotoxin A on the rat gastrointestinal tract. Infect Immun 1984;44:234-40.
42. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994;120:771-83.
43. Marrack P, Blackman M, Kushinir E, Kappler J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med 1990;171:445-64.
44. Ikegami T, Dinarello CA, Gill DM, Wolf SM. Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome. J Clin Invest 1984;73:1312.
45. Jupin C, Anderson S, Damais C, Eardley DD, Pier GB. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factor and gamma interferon. J Exp Med 1988;167:752-61.
46. Scheuber PH, Denzlinger D, Wilker D, Beck G, Kappler D, Hammer DK. Staphylococcal enterotoxin B as a nonimmunological mast cell stimulus in primates: the role of endogenous cysteinyl leukotrienes. Int Arch Allergy Appl Immunol 1987;82:289-91.
47. Holmdahl R, Jansson L, Anderson M, Jonsson R. Genetic, hormonal and behavioral influence on spontaneously developing arthritis in normal mice. Clin Exp Immunol 1992;88:467-72.
48. Trentham DE, Dynesius-Trentham RA, Orav EJ et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993;261:1727-30.
49. Thomson HSG, Staines NA. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 1986;64:581-6.
50. Nagler-Anderson C, Bober LA, Robinson ME et al. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 1986;83:7443-6.
51. Simon LS, Goodman T. NSAID-induced gastrointestinal toxicity. Bull Rheum Dis 1995;44:1-5.
52. Kalz K, Hollander D. Intestinal mucosal permeability and rheumatological diseases. Baillière's Clin Rheumatol 1989;3:271-84.
53. Mielants M, Veys EM, Cuvelier C, DeVos M. Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol 1988;27:95-105.
54. Gravallese EM, Mantrowitiz FG. Arthritis manifestations of inflammatory bowel disease. Am J Gastroenterol 1988;83:703-9.